I was wondering how you’d manage to spin your narrative, I...

I was wondering how you’d manage to spin your narrative, I didn’t think you would just go ahead and ignore the amazing sales growth altogether!

Your “I told you so” falls flat once you see the real story.

The spike in cash burn, from $642k to $1.15m was a deliberate, one-off investment in scaling production, stocking up inventory and staging a massive China launch.

That half-million fueled a 490% YoY jump in powder sales to $736k real revenue from a brand-new formula, not marketing fluff. If you didn’t notice in those pictures, mum and baby stores all over China are stocking this and the marketing and sales machine is just starting!

Forget cherry-picked percentages? going from 125k to 736k in a year is over half a million dollars of fresh quarterly income.

After a transition driven first half, Q3 delivered $1.6m in sales, the strongest March quarter ever, positioning AHF to surpass FY24 on an annualised basis, even after shedding legacy assets.

And the so called “Andy Zhang risk”? He’s now a board director, shareholder and partner on a demand-driven M2C platform, turning his China network into actual orders instead of piling up unsold stock.

With nearly four quarters of cash runway plus a 1.22m credit line, backed by record sales and a proven China strategy this isn’t desperation; it’s smart scaling.

Q3 FY25 proves AHF’s pivot to premium infant nutrition is working, and the best is yet to come.